
Gritstone - Wikipedia
Gritstone or grit is a hard, coarse-grained, siliceous sandstone. This term is especially applied to such sandstones that are quarried for building material. British gritstone was used for millstones to mill flour, to grind wood into pulp for paper and for grindstones to sharpen blades.
一家癌症疫苗biotech宣告破产 - 推荐阅读 - PharmaTEC制药网
2024年10月11日 · Gritstone 打算利用由法院管理的重组程序来保值并支持其正在进行的战略选择过程。 公司正在与作为跟踪竞标者或计划发起人的一方进行讨论,并打算最早于下周向法院提交一份协议,以便达成价值最大化交易。
粗砂岩 - 维基百科,自由的百科全书
粗砂岩(英語: Gritstone )是一種堅硬的粗粒矽質砂岩。 該名詞常被用于建築材料所用的砂岩。 在英國粗砂岩常被用作磨石來磨麵粉,將木材磨成紙漿,以及用作磨刀石。“粗砂岩”常指由棱角顆粒組成的砂岩。 也包含小鵝卵石在内 [1] 。
Gritstone bio - Wikipedia
Gritstone bio was a clinical-stage American biotechnology company which attempted to develop cancer and infectious disease immunotherapies and vaccines. It was founded in August 2015 as Gritstone Oncology, Inc., with offices in Emeryville, California. In September 2021 it raised $55.0 million from the sale of 5,000,000 shares. [1]
Gritstone bio assets auctioned for $21.25 million - Investing.com
2024年12月15日 · Gritstone bio, Inc., a biotechnology firm specializing in biological products, disclosed in a recent 8-K filing that it has auctioned off its assets, following a voluntary Chapter 11...
Gritstone files for bankruptcy in hope of keeping R&D afloat
2024年10月10日 · Gritstone bio may have left no stone unturned when it came to searching for a financial rescue, but the vaccine biotech has decided that all roads now lead to bankruptcy.
Gritstone bio (GRTSQ) Stock Price & Overview - Stock Analysis
6 天之前 · Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing vaccine-based immunotherapy candidates against cancer and infectious diseases. Its primary product candidate is GRANITE, an individualized immunotherapy candidate, which is in Phase 2/3 clinical trials for the treatment of microsatellite stable colorectal cancers ...
Gritstone bio公布个性化癌症疫苗GRANITE联用治疗MSS-CRC的临 …
加利福尼亚州埃默里维尔,2024年4月1日(环球通讯社)--致力于开发世界上最有效疫苗的临床阶段生物技术公司Gritstone bio,Inc.(纳斯达克:GRTS)今天宣布了正在进行的2/3期研究的积极初步数据,该研究评估了GRANITE(其个性化新抗原癌症疫苗)在一线转移性微卫星稳定结直肠癌(MSS-CRC)中的作用。
祝贺!Gritstone今日登陆纳斯达克,打造个体化抗癌疗法 - 知乎
Gritstone成立于2015年,是一家专注开发肿瘤特异性免疫疗法的生物技术公司。我们知道,在不同患者的不同肿瘤上,会出现具有高度特异性的新抗原。 我们知道,在不同患者的不同肿瘤上,会出现具有高度特异性的新抗原。
Buy Men's T-Shirts, Shirts Online @ Best Casual Cloth
All the clothing products are made from 100% premium quality fabric. Highly Secured SSL-Protected Payment Gateway. Return or exchange the orders within 7 days of delivery.